title: Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4.
authors.affiliation: Departments of Ophthalmology, Children's Hospital of Michigan, Detroit Medical Center, Wayne State University, Detroit, USA. stevenpdunn@ameritech.net
authors.forename: Steven P
authors.initials: SP
authors.lastname: Dunn
authors.forename: David G
authors.initials: DG
authors.lastname: Heidemann
authors.forename: Christopher Y C
authors.initials: CY
authors.lastname: Chow
authors.forename: David
authors.initials: D
authors.lastname: Crockford
authors.forename: Nabila
authors.initials: N
authors.lastname: Turjman
authors.forename: Janet
authors.initials: J
authors.lastname: Angel
authors.forename: Christian B
authors.initials: CB
authors.lastname: Allan
authors.forename: Gabriel
authors.initials: G
authors.lastname: Sosne
mesh_terms: D000369:Aged, 80 and over; D002908:Chronic Disease; D057176:Compassionate Use Trials; D003316:Corneal Diseases / Q000188:drug therapy* / Q000209:etiology; D048909:Diabetes Complications; D019573:Epithelium, Corneal / Q000187:drug effects* / Q000473:pathology; D005260:Female; D006563:Herpes Zoster Ophthalmicus / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000008:administration & dosage*; D013947:Thymosin / Q000008:administration & dosage*; D000099201:Thymosin beta(4)
chemical_list: D009883:Ophthalmic Solutions; D013947:Thymosin; D000099201:Thymosin beta(4)